Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76326 - 76350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamibarotene	Investigational	ALOX5AP	241	upregulated	tamibarotene results in increased expression of ALOX5AP mRNA	13q12.3	A24376
Tamibarotene	Investigational	AMD1	262	downregulated	tamibarotene results in decreased expression of AMD1 mRNA	6q21	A24376
Tamibarotene	Investigational	ANKRD17	26057	downregulated	tamibarotene results in decreased expression of ANKRD17 mRNA	4q13.3	A24376
Tamibarotene	Investigational	ANXA2	302	downregulated	tamibarotene results in decreased expression of ANXA2 mRNA	15q22.2	A24376
Tamibarotene	Investigational	AP1S2	8905	upregulated	tamibarotene results in increased expression of AP1S2 mRNA	Xp22.2	A24376
Tamibarotene	Investigational	APC	324	downregulated	tamibarotene results in decreased expression of APC mRNA	5q22.2	A24376
Tamibarotene	Investigational	ARHGAP4	393	upregulated	tamibarotene results in increased expression of ARHGAP4 mRNA	Xq28	A24376
Tamibarotene	Investigational	ARHGAP45	23526	upregulated	tamibarotene results in increased expression of ARHGAP45 mRNA	19p13.3	A24376
Tamibarotene	Investigational	ARHGAP8	23779	upregulated	tamibarotene results in increased expression of ARHGAP8 mRNA	22q13.31	A20516
Tamibarotene	Investigational	ARL4C	10123	downregulated	tamibarotene results in decreased expression of ARL4C mRNA	2q37.1	A24376
Tamibarotene	Investigational	ASB2	51676	upregulated	tamibarotene results in increased expression of ASB2 mRNA	14q32.12	A20516
Tamibarotene	Investigational	ATP6V0A1	535	upregulated	tamibarotene results in increased expression of ATP6V0A1 mRNA	17q21.2	A24376
Tamibarotene	Investigational	ATP6V0A2	23545	downregulated	tamibarotene results in decreased expression of ATP6V0A2 mRNA	12q24.31	A24376
Tamibarotene	Investigational	ATRX	546	downregulated	tamibarotene results in decreased expression of ATRX mRNA	Xq21.1	A24376
Tamibarotene	Investigational	AXIN1	8312	upregulated	tamibarotene results in increased expression of AXIN1 mRNA	16p13.3	A24376
Tamibarotene	Investigational	AZU1	566	upregulated	tamibarotene results in increased expression of AZU1 mRNA	19p13.3	A24376
Tamibarotene	Investigational	BAK1	578	upregulated	tamibarotene results in increased expression of BAK1 mRNA	6p21.31	A24376
Tamibarotene	Investigational	BCL11A	53335	downregulated	tamibarotene results in decreased expression of BCL11A mRNA	2p16.1	A24376
Tamibarotene	Investigational	BCL2	596	downregulated	tamibarotene results in decreased expression of BCL2 mRNA	18q21.33	A24377 A24376
Tamibarotene	Investigational	BCL2A1	597	upregulated	tamibarotene results in increased expression of BCL2A1 mRNA	15q25.1	A24376
Tamibarotene	Investigational	BCL7A	605	downregulated	tamibarotene results in decreased expression of BCL7A mRNA	12q24.31	A24376
Tamibarotene	Investigational	BCLAF1	9774	downregulated	tamibarotene results in decreased expression of BCLAF1 mRNA	6q23.3	A24376
Tamibarotene	Investigational	BLMH	642	downregulated	tamibarotene results in decreased expression of BLMH mRNA	17q11.2	A24376
Tamibarotene	Investigational	BPI	671	upregulated	tamibarotene results in increased expression of BPI mRNA	20q11.23	A24376
Tamibarotene	Investigational	BRCA1	672	downregulated	tamibarotene results in decreased expression of BRCA1 mRNA	17q21.31	A24376

Displaying entries 76326 - 76350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability